Continuing Education

Mark your calendars for the ATRIUM Cardiology Collaborative's Online Patient Safety Continuing Education Program scheduled for Wednesday, November 8 at 12 p.m., with an encore presentation at 7 p.m.

About the Event:

The ATRIUM Cardiology Collaborative will offer a one-hour, online continuing education program this fall. Many drug-related myths exist in the area of cardiovascular disease (CVD), which may place patients at risk or prevent them from receiving optimal medication therapy. Because CVD is a common comorbidity among patients with other chronic diseases, pharmacists across practice settings are likely to encounter scenarios in which these myths are used to justify therapy decision-making. The purpose of the ATRIUM Continuing Education Program is to educate pharmacists on four of these myths so that they may address them in their practice and optimize medication therapy used to treat common cardiovascular disorders. This program is an application-based educational activity targeted to pharmacists practicing in all settings.


To register for this event, please complete the online registration form. The cost to register for this event is as follows:

  • Continuing Education Program Only: $15

Learning Objectives:

At the completion of this activity, the participant will be able to:

  1. Describe limitations in the evidence to support an interaction between cocaine and beta blockers.
  2. Explain why carvedilol is no better than other evidence-based beta blockers in patients with heart failure and elevated blood pressure.
  3. Distinguish which patients with coronary artery disease should receive an angiotensin-converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB).
  4. Explain why aspirin is no safer than an anticoagulant in older patients with atrial fibrillation at risk for major hemorrhage.


This event will be offered at the following location for the convenience of our faculty, preceptors, and residents:

Online via GoToMeeting™
Instructions for participation will be sent by 5 p.m. on November 1.

For More Information:

More information, including registration, faculty, and an agenda can be found on this website. If you have any additional questions, please contact the Department of Pharmacy Practice and Science at (410) 706-7338 or


Accredited by the Accreditation Council for Pharmacy Education The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this activity requires participants' signature on a signature sheet, participation in the entire activity, and completion of an online activity evaluation survey. Statements of credit will be posted to participants' CPE Monitor profile within three weeks of successful completion of this activity.